# PRLD (Prelude Therapeutics Inc.) - SEC EDGAR Financial Statements

> Prelude Therapeutics Inc. reported $21.57M in revenue and a net loss of $53.31M for the trailing twelve months ended September 30, 2026 (down 13.1% year over year), with a -283.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/PRLD
- Markdown: https://convexityos.com/fundamentals/PRLD.md
- SEC CIK: 0001678660
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001678660&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $21.57M | -13.1% YoY |
| Operating Income | TTM | -$61.24M | -283.9% margin |
| Net Income | TTM | -$53.31M | -247.1% net margin |
| Diluted EPS | TTM | -$0.52 | Split-adjusted |
| Free Cash Flow | TTM | -$27.95M | -129.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $140.0M | Total debt: $17.56M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $12.14M | $7.00M | -- | -- | -- | -- | -- |
| Research & Development | $94.30M | $118.0M | $103.4M | $92.89M | $86.78M | $48.18M | $24.28M |
| Total Operating Expenses | $116.7M | $146.7M | $132.3M | $123.5M | $113.7M | $58.76M | $28.11M |
| **Operating Income** | -$104.6M | -$139.7M | -$132.3M | -$123.5M | -$113.7M | -$58.76M | -$28.11M |
| **EBITDA** | -$102.9M | -$137.9M | -$131.1M | -$122.2M | -$112.8M | -$58.22M | -$27.73M |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$99.50M | -$127.2M | -$121.8M | -$115.4M | -$111.7M | -$56.93M | -$27.57M |
| Basic EPS | -$1.29 | -$1.68 | -$2.02 | -$2.44 | -$2.43 | -$4.56 | -$16.52 |
| **Diluted EPS** | -$1.29 | -$1.68 | -$2.02 | -$2.44 | -$2.43 | -$4.56 | -$16.52 |
| Basic Shares Outstanding | 77.0M | 75.8M | 60.4M | 47.4M | 46.0M | 12.5M | 1.7M |
| Diluted Shares Outstanding | 77.0M | 75.8M | 60.4M | 47.4M | 46.0M | 12.5M | 1.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.65M | $5.70M | $4.58M | $5.64M | $6.50M | $0 | $0 | -- |
| Research & Development | $14.83M | $16.13M | $13.60M | $17.99M | $21.71M | $25.78M | $28.82M | $31.62M |
| Total Operating Expenses | $19.91M | $21.16M | $18.76M | $22.99M | $26.92M | $32.19M | $34.61M | $37.83M |
| **Operating Income** | -$14.27M | -$15.45M | -$14.18M | -$17.35M | -$20.42M | -$32.19M | -$34.61M | -$33.83M |
| **EBITDA** | -$13.92M | -$15.10M | -$13.79M | -$16.93M | -$19.99M | -$31.76M | -$34.17M | -$33.34M |
| **Net Income** | -$12.54M | -$13.92M | -$10.38M | -$16.46M | -$19.73M | -$31.23M | -$32.09M | -$28.73M |
| Basic EPS | -$0.12 | -$0.14 | -$0.13 | -- | -$0.26 | -$0.41 | -$0.42 | -- |
| **Diluted EPS** | -$0.12 | -$0.14 | -$0.13 | -- | -$0.26 | -$0.41 | -$0.42 | -- |
| Basic Shares Outstanding | 103.1M | 98.4M | 82.5M | -- | 76.1M | 76.0M | 76.0M | -- |
| Diluted Shares Outstanding | 103.1M | 98.4M | 82.5M | -- | 76.1M | 76.0M | 76.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.26M | $12.47M | $25.29M | $30.61M | $31.83M | $218.3M | $18.88M |
| Short-Term Investments | $67.96M | $121.1M | $207.6M | $171.1M | $259.4M | -- | -- |
| **Cash & Short-Term Investments** | $103.2M | $133.6M | $232.9M | $201.7M | $291.2M | $218.3M | $18.88M |
| **Total Current Assets** | $105.7M | $135.9M | $235.6M | $204.4M | $295.1M | $220.8M | $20.22M |
| Property, Plant & Equipment, Net | $5.11M | $6.77M | $7.33M | $4.91M | $3.93M | $2.48M | $1.65M |
| **Total Non-Current Assets** | $35.62M | $39.62M | $42.08M | $16.12M | $9.98M | $2.78M | $1.65M |
| **Total Assets** | $141.3M | $175.5M | $277.7M | $220.5M | $305.1M | $223.6M | $21.87M |
| Accounts Payable | $3.98M | $7.73M | $4.58M | $6.78M | $7.84M | $3.92M | $1.97M |
| Deferred Revenue (Current) | $33.73M | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $52.99M | $25.64M | $21.83M | $21.70M | $19.20M | $11.38M | $4.83M |
| Deferred Revenue (Non-Current) | $1.80M | $0 | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $2.84M | $3.09M | $3.34M | $3.36M | $0 | $32K | $5.0K |
| **Total Non-Current Liabilities** | $19.68M | $18.41M | $18.75M | $3.36M | $0 | $32K | $5.0K |
| **Total Liabilities** | $72.68M | $44.06M | $40.58M | $25.06M | $19.20M | $11.41M | $4.84M |
| **Total Debt (incl. Leases)** | $17.79M | $18.02M | $16.89M | $1.83M | $1.74M | -- | -- |
| Retained Earnings | -$683.1M | -$583.6M | -$456.4M | -$334.6M | -$219.1M | -$107.4M | -$50.50M |
| Accumulated Other Comp. Income | $8.0K | $35K | $223K | -$1.69M | -$711K | -- | -- |
| **Total Stockholders' Equity** | $68.64M | $131.5M | $237.1M | $195.4M | $285.9M | $212.2M | -$49.41M |
| Total Equity | $68.64M | $131.5M | $237.1M | $195.4M | $285.9M | $212.2M | -$49.41M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $23.41M | $26.33M | $21.76M | $35.26M | $47.53M | $25.75M | $40.27M | $12.47M |
| Short-Term Investments | $116.6M | $125.4M | $59.80M | $67.96M | $7.42M | $47.46M | $58.80M | $121.1M |
| **Cash & Short-Term Investments** | $140.0M | $151.8M | $81.55M | $103.2M | $54.96M | $73.22M | $99.07M | $133.6M |
| **Total Current Assets** | $142.4M | $154.9M | $84.59M | $105.7M | $58.33M | $76.88M | $102.4M | $135.9M |
| Property, Plant & Equipment, Net | $4.06M | $4.40M | $4.72M | $5.11M | $5.53M | $5.96M | $6.39M | $6.77M |
| **Total Non-Current Assets** | $33.06M | $34.47M | $35.05M | $35.62M | $36.42M | $38.04M | $38.86M | $39.62M |
| **Total Assets** | $175.5M | $189.4M | $119.6M | $141.3M | $94.75M | $114.9M | $141.3M | $175.5M |
| Accounts Payable | $2.97M | $2.03M | $2.07M | $3.98M | $2.53M | $4.96M | $5.83M | $7.73M |
| Deferred Revenue (Current) | $19.60M | $25.25M | $30.95M | $33.73M | -- | -- | -- | $0 |
| **Total Current Liabilities** | $33.93M | $38.04M | $41.72M | $52.99M | $18.19M | $20.91M | $19.79M | $25.64M |
| Deferred Revenue (Non-Current) | $0 | $0 | $0 | $1.80M | -- | -- | -- | $0 |
| Other Non-Current Liabilities | $2.65M | $2.72M | $2.78M | $2.84M | $2.90M | $2.97M | $3.03M | $3.09M |
| **Total Non-Current Liabilities** | $17.42M | $17.59M | $17.74M | $19.68M | $18.03M | $18.17M | $18.30M | $18.41M |
| **Total Liabilities** | $51.35M | $55.63M | $59.46M | $72.68M | $36.22M | $39.08M | $38.08M | $44.06M |
| **Total Debt (incl. Leases)** | $17.56M | $17.65M | $17.72M | $17.79M | $17.85M | $17.92M | $17.92M | $18.02M |
| Retained Earnings | -$719.9M | -$707.4M | -$693.4M | -$683.1M | -$666.6M | -$646.9M | -$615.6M | -$583.6M |
| Accumulated Other Comp. Income | -$533K | -$227K | -$41K | $8.0K | $2.0K | -$1.0K | $12K | $35K |
| **Total Stockholders' Equity** | $124.1M | $133.7M | $60.18M | $68.64M | $58.53M | $75.84M | $103.2M | $131.5M |
| Total Equity | $124.1M | $133.7M | $60.18M | $68.64M | $58.53M | $75.84M | $103.2M | $131.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$99.50M | -$127.2M | -$121.8M | -$115.4M | -$111.7M | -$56.93M | -$27.57M |
| Depreciation & Amortization | $1.71M | $1.77M | $1.17M | $1.32M | $915K | $542K | $382K |
| Stock-Based Compensation | $11.91M | $21.34M | $25.62M | $25.14M | $20.93M | $5.58M | $846K |
| Change in Payables | -$3.92M | $3.31M | -$2.27M | -$347K | $3.90M | $1.16M | $546K |
| **Operating Cash Flow** | -$56.30M | -$102.9M | -$107.1M | -$83.73M | -$83.53M | -$46.18M | -$25.66M |
| Capital Expenditure | -$67K | -$764K | -$3.51M | -$3.02M | -$2.32M | -$621K | -$780K |
| **Free Cash Flow** | -$56.37M | -$103.7M | -$110.6M | -$86.75M | -$85.85M | -$46.80M | -$26.45M |
| Purchases of Investments | -$100.9M | -$52.69M | -$221.6M | -$119.2M | -$261.5M | -- | -- |
| **Investing Cash Flow** | $53.46M | $90.19M | -$34.65M | $81.69M | -$263.8M | -$621K | -$780K |
| Common Stock Issued | -- | -- | -- | -- | $161.4M | -- | -- |
| **Financing Cash Flow** | $24.82M | -$120K | $136.4M | $815K | $164.9M | $246.2M | $29.73M |
| **Net Change in Cash** | $21.97M | -$12.82M | -$5.31M | -$1.22M | -$182.4M | $199.4M | $3.28M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.54M | -$13.92M | -$10.38M | -$16.46M | -$19.73M | -$31.23M | -$32.09M | -$28.73M |
| Depreciation & Amortization | $341K | $353K | $391K | $418K | $425K | $433K | $435K | $489K |
| Stock-Based Compensation | $2.03M | $2.03M | $2.00M | $1.84M | $2.42M | $3.81M | $3.83M | $3.77M |
| Change in Payables | $1.02M | -$154K | -$1.88M | $1.27M | -$2.43M | -$850K | -$1.91M | $1.81M |
| **Operating Cash Flow** | -$13.78M | -$15.57M | -$21.68M | $23.12M | -$19.11M | -$26.07M | -$34.23M | -$20.74M |
| Capital Expenditure | -$35K | $0 | $0 | $0 | $0 | -$20K | -$47K | -$53K |
| **Free Cash Flow** | -$13.81M | -$15.57M | -$21.68M | $23.12M | -$19.11M | -$26.09M | -$34.28M | -$20.80M |
| Purchases of Investments | -$6.72M | -$89.97M | $0 | -$66.74M | $0 | -$24.66M | -$9.46M | -$7.33M |
| **Investing Cash Flow** | $9.02M | -$65.50M | $8.50M | -$60.34M | $40.09M | $11.52M | $62.19M | $22.12M |
| **Financing Cash Flow** | $1.17M | $85.82M | -$314K | $24.94M | -$5.0K | $37K | -$160K | -$34K |
| **Net Change in Cash** | -$3.60M | $4.74M | -$13.50M | -$12.28M | $20.97M | -$14.52M | $27.80M | $1.34M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -861.3% | -1995.9% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -819.6% | -1816.8% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -145.0% | -96.7% | -51.4% | -59.1% | -39.1% | -26.8% | -- |
| Return on Assets (ROA) | -70.4% | -72.5% | -43.9% | -52.4% | -36.6% | -25.5% | -126.1% |
| Current Ratio | 1.99x | 5.30x | 10.79x | 9.42x | 15.37x | 19.41x | 4.18x |
| Quick Ratio | 1.95x | 5.21x | 10.67x | 9.30x | 15.17x | 19.19x | 3.90x |
| Debt to Equity | 0.26x | 0.14x | 0.07x | 0.01x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | +73.4% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -283.9% | -300.6% | -503.2% | -861.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -247.1% | -269.7% | -465.3% | -819.6% | -- | -- | -- | -- |
| Return on Equity (ROE) | -42.9% | -45.2% | -129.3% | -145.0% | -191.0% | -163.9% | -123.9% | -96.7% |
| Return on Assets (ROA) | -30.4% | -31.9% | -65.0% | -70.4% | -118.0% | -108.2% | -90.5% | -72.5% |
| Current Ratio | 4.20x | 4.07x | 2.03x | 1.99x | 3.21x | 3.68x | 5.18x | 5.30x |
| Quick Ratio | 4.13x | 3.99x | 1.95x | 1.95x | 3.02x | 3.50x | 5.01x | 5.21x |
| Debt to Equity | 0.14x | 0.13x | 0.29x | 0.26x | 0.31x | 0.24x | 0.17x | 0.14x |
| **Revenue Growth (YoY)** | -13.1% | -- | -- | -- | +116.7% | -- | -- | -- |

## Related Companies

[NEPH (Nephros, Inc.)](https://convexityos.com/fundamentals/NEPH), [BRFH (Barfresh Food Group Inc.)](https://convexityos.com/fundamentals/BRFH), [ILLR (Triller Group Inc.)](https://convexityos.com/fundamentals/ILLR), [RLBY (Reliability Incorporated)](https://convexityos.com/fundamentals/RLBY), [PURR (Hyperliquid Strategies Inc)](https://convexityos.com/fundamentals/PURR), [SOTK (Sono Tek Corp.)](https://convexityos.com/fundamentals/SOTK), [QMCI (QuoteMedia, Inc.)](https://convexityos.com/fundamentals/QMCI), [MAYS (Mays J W Inc.)](https://convexityos.com/fundamentals/MAYS)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
